Serum metabolomics reveals higher levels of polyunsaturated fatty acids in lepromatous leprosy: Potential markers for susceptibility and pathogenesis

PLoS Neglected Tropical Diseases

Volumn 5, Issue 9, 2011, Pages

  Al Mubarak, Reem ^a   Vander Heiden, Jason ^a   Broeckling, Corey D ^a   Balagon, Marivic ^b   Brennan, Patrick J ^a   Vissa, Varalakshmi D ^a  

^a Department of Ecosystem Science and Sustainability   (United States)

^b Leonard Wood Memorial Center for Leprosy Research Philippines   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; BIOLOGICAL MARKER; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; UNSATURATED FATTY ACID;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL VIRULENCE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; LEPROMATOUS LEPROSY; LIPID BLOOD LEVEL; MALE; METABOLOMICS; MYCOBACTERIUM LEPRAE; PATHOGENESIS; ADULT; BLOOD; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLOME; MIDDLE AGED; PATHOGENICITY; PATHOPHYSIOLOGY; SERUM;

ADULT; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; LEPROSY, LEPROMATOUS; MALE; MASS SPECTROMETRY; METABOLOME; MIDDLE AGED; MYCOBACTERIUM LEPRAE; SERUM;

EID: 80053456051     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001303     Document Type: Article

References (50)

1. Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, et al. (2006) The continuing challenges of leprosy. Clin Microbiol Rev 19: 338-381.
2. Scollard DM, (2008) The biology of nerve injury in leprosy. Lepr Rev 79: 242-253.
3. World Health Organization (2010) Global leprosy situation, 2010. Wkly Epidemiol Rec 85: 337-348.
4. Moet FJ, Schuring RP, Pahan D, Oskam L, Richardus JH, (2008) The prevalence of previously undiagnosed leprosy in the general population of northwest bangladesh. PLoS Negl Trop Dis 2: e198.
5. Ridley DS, Jopling WH, (1966) Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 34: 255-273.
6. Alter A, Grant A, Abel L, Alcaïs A, Schurr E, (2011) Leprosy as a genetic disease. Mamm Genome 22: 19-31.
7. Alter A, Huong NT, Singh M, Orlova M, Van Thuc N, et al. (2011) Human leukocyte antigen class I region single-nucleotide polymorphisms are associated with leprosy susceptibility in Vietnam and India. J Infect Dis 203: 1274-1281.
8. Hashimoto K, Maeda Y, Kimura H, Suzuki K, Masuda A, et al. (2002) Mycobacterium leprae infection in monocyte-derived dendritic cells and its influence on antigen-presenting function. Infect Immun 70: 5167-5176.
9. Mattos KA, D'Avila H, Rodrigues LS, Oliveira VGC, Sarno EN, et al. (2010) Lipid droplet formation in leprosy: Toll-like receptor-regulated organelles involved in eicosanoid formation and Mycobacterium leprae pathogenesis. J Leukoc Biol 87: 371-384.
10. Misch EA, Berrington WR, Vary JC, Hawn TR, (2010) Leprosy and the human genome. Microbiol Mol Biol Rev 74: 589-620.
11. Mira MT, Alcaïs A, Nguyen VT, Moraes MO, Di Flumeri C, et al. (2004) Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 427: 636-640.
12. Moraes MO, Cardoso CC, Vanderborght PR, Pacheco AG, (2006) Genetics of host response in leprosy. Lepr Rev 77: 189-202.
13. Harbige LS, (2003) Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3. Lipids 38: 323-341.
14. Zeyda M, Säemann MD, Stuhlmeier KM, Mascher DG, Nowotny PN, et al. (2005) Polyunsaturated fatty acids block dendritic cell activation and function independently of NF-kappa-B activation. J Biol Chem 280: 14293-14301.
15. Cole ST, Eiglmeier K, Parkhill J, James KD, Thomson NR, et al. (2001) Massive gene decay in the leprosy bacillus. Nature 409: 1007-1011.
16. Cruz D, Watson AD, Miller CS, Montoya D, Ochoa MT, et al. (2008) Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy. J Clin Invest 118: 2917-2928.
17. Ahaley SK, Sardeshmukh AS, Suryakar AN, Samson PD, (1992) Correlation of serum lipids and lipoproteins in leprosy. Indian J Lepr 64: 91-98.
18. Memon R, Kifayet A, Shahid F, Lateef A, Chiang T, et al. (1997) Low serum HDL-cholesterol is associate with raised tumor necrosis factor-alpha during ENL reactions. Int J Lepr Other Mycobact Dis 65: 1-11.
19. Chen X, Liu L, Palacios G, Gao J, Zhang N, et al. (2010) Plasma metabolomics reveals biomarkers of the atherosclerosis. J Sep Sci 33: 2776-2783.
20. Ramautar R, Mayboroda OA, Somsen GW, de Jong GJ, (2011) CE-MS for metabolomics: Developments and applications in the period 2008-2010. Electrophoresis 32: 52-65.
21. Wang D-C, Sun C-H, Liu L-Y, Sun X-H, Jin X-W, et al. (2010) Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer's disease. Neurobiol Aging in press.
22. Sakamuri RM, Kimura M, Li W, Kim H-C, Lee H, et al. (2009) Population-based molecular epidemiology of leprosy in Cebu, Philippines. J Clin Microbiol 47: 2844-2854.
23. Ridley DS, (1964) Bacterial indices. In: Cochrane RG, Davey TF, editors. Leprosy in Theory and Practice Baltimore, MD The Williams & Wilkins Co pp. 620-622.
24. R Development Core Team (2010) R: A Language and Environment for Statistical Computing. Vienna Austria R Foundation for Statistical Computing 1: ISBN 3-900051-07-0. Available: http://www.r-project.org.
25. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, et al. (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12: 77.
26. Fahy E, Sud M, Cotter D, Subramaniam S, (2007) LIPID MAPS online tools for lipid research. Nucleic Acids Res 35: W606-612.
27. Suhre K, Schmitt-Kopplin P, (2008) MassTRIX: mass translator into pathways. Nucleic Acids Res 36: W481-484.
28. Kerwin JL, Wiens AM, Ericsson LH, (1996) Identification of fatty acids by electrospray mass spectrometry and tandem mass spectrometry. J Mass Spectrom 31: 184-192.
29. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M, (2010) KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 38: D355-360.
30. Murphy RC, (2002) Mass Spectrometry of Phospholipids: Tables of Molecular and Product Ions Denver Illuminati Press.
31. Sumner LW, Amberg A, Barrett D, Beale MH, Beger R, et al. (2007) Proposed minimum reporting standards for chemical analysis. Metabolomics 3: 211-221.
32. Reis A, Domingues P, Ferrer-Correia AJV, Domingues MRM, (2004) Tandem mass spectrometry of intact oxidation products of diacylphosphatidylcholines: evidence for the occurrence of the oxidation of the phosphocholine head and differentiation of isomers. J Mass Spectrom 39: 1513-1522.
33. Zweig MH, Campbell G, (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39: 561-577.
34. Bleharski JR, Li H, Meinken C, Graeber TG, Ochoa M-T, et al. (2003) Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science 301: 1527-1530.
35. Martins M, (2008) Challenges in the post genomic era for the development of tests for leprosy diagnosis. Rev Soc Bras Med Trop 41: 89-94.
36. Wright S, Morse N, Manku MS, (1991) Essential fatty acids in plasma of patients with leprosy. Int J Lepr Other Mycobact Dis 59: 271-277.
37. Blaho VA, Buczynski MW, Brown CR, Dennis EA, (2009) Lipidomic analysis of dynamic eicosanoid responses during the induction and resolution of Lyme arthritis. J Biol Chem 284: 21599-21612.
38. Griffiths WJ, Koal T, Wang Y, Kohl M, Enot DP, et al. (2010) Targeted metabolomics for biomarker discovery. Angew Chem Int Ed Engl 49: 5426-5445.
39. Calder PC, (2001) Polyunsaturated fatty acids, inflammation, and immunity. Lipids 36: 1007-1024.
40. Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Willett WC, et al. (2003) Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 108: 155-160.
41. Deckelbaum RJ, Calder PC, (2010) Dietary n-3 and n-6 fatty acids: are there "bad" polyunsaturated fatty acids? Curr Opin Clin Nutr Metab Care 13: 123-124.
42. Ferrucci L, Cherubini A, Bandinelli S, Bartali B, Corsi A, et al. (2006) Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 91: 439-446.
43. Bonilla DL, Ly LH, Fan Y-Y, Chapkin RS, McMurray DN, (2010) Incorporation of a dietary omega 3 fatty acid impairs murine macrophage responses to Mycobacterium tuberculosis. PLoS One 5: e10878.
44. Jordao L, Lengeling A, Bordat Y, Boudou F, Gicquel B, et al. (2008) Effects of omega-3 and-6 fatty acids on Mycobacterium tuberculosis in macrophages and in mice. Microbes Infect 10: 1379-1386.
45. Anes E, Kühnel MP, Bos E, Moniz-Pereira J, Habermann A, et al. (2003) Selected lipids activate phagosome actin assembly and maturation resulting in killing of pathogenic mycobacteria. Nat Cell Biol 5: 793-802.
46. Bansal SN, Jain VK, Dayal S, Nagpal RK, (1997) Serum lipid profile in leprosy. Indian J Dermatol Venereol Leprol 63: 71-81.
47. Liu PT, Stenger S, Tang DH, Modlin RL, (2007) Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 179: 2060-2063.
48. Sheikh AM, Ochi H, Manabe A, Masuda J, (2005) Lysophosphatidylcholine posttranscriptionally inhibits interferon-gamma-induced IP-10, Mig and I-Tac expression in endothelial cells. Cardiovasc Res 65: 263-271.
49. Rao Pn, Pratap D, Ramana Reddy A, Sujai S, (2006) Evaluation of leprosy patients with 1 to 5 skin lesions with relevance to their grouping into paucibacillary or multibacillary disease. Indian J Dermatol Venereol Leprol 72: 207-210.
50. Tobin DM, Vary JC, Ray JP, Walsh GS, Dunstan SJ, et al. (2010) The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 140: 717-730.